Tharimmune, Inc. , a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases.
Tharimmune stock last closed at $3.99, up 4.01% from the previous day, and has increased 48.21% in one year. It has overperformed other stocks in the Biotechnology industry by 1.07 percentage points. Tharimmune stock is currently +319.12% from its 52-week low of $0.95, and -56.06% from its 52-week high of $9.08.
At the moment, there are 4.64M shares of THAR outstanding. The market value of THAR is $18.49M. In the past 24 hours, 4.94M THAR shares were traded.
You need a brokerage account to access the NASDAQ market and buy THAR shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal info so you can invest in THAR today.
Now that you've finished signing up on the best free stock trading app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of transferring funds into your brokerage account.
Once you have figured out the best place to buy Tharimmune stock, it's crucial to research their stock before you invest, so you actually comprehend the risk and opportunity.
WallStreetZen was built to help average investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on THAR's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge THAR's true value.
Using relative valuations ratios:
You can access more valuation analysis on THAR's stock here.
You can dive deeper into what analysts are forecasting on the Tharimmune stock forecast page.
In the last year, insiders at THAR have bought more shares than they have sold.
Sireesh Appajosyula, Chief Executive Officer of THAR, was the latest THAR insider to buy. They bought $89,992.88 worth of THAR shares on Jun 20, 2025.
Research more about who owns THAR stock here.
No, Tharimmune doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two primary options:
Hit the Open Trade button and eToro will place the order.
If you require more help buying stocks on eToro, watch the how to video below:
Now that you own some THAR shares, you'll want to stay up-to-date on your new investment.
Put THAR on a watchlist to track the latest developments regarding your THAR stock.
To summarize, here are the 6 steps you need to take to buy Tharimmune stock right now:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Tharimmune, click the button below.